No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
EOM Pharmaceutical Holdings Provides an Update on Its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings Announces Topline Results of Its COVID-19 Clinical Trial of EOM613 in Brazil
IPO Roundup: Richtech Robotics, Triller and More
EOM Pharmaceuticals Shelves Plans to Uplist Shares, Raise $15M
EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.
EOM Pharmaceuticals files to uplist to Nasdaq
Unlock the Full List